Table 1.
Baseline characteristics of patients enrolled in TNR
| Characteristic | (n=22) |
|---|---|
| Age (years) | |
| Median (IQR) | 66.0 (44.0-71.0) |
| Male (%) | 13 (59.1) |
| Age at onset (years) | |
| Median (IQR) | 63.0 (51.5-69.5) |
| Mean duration of symptoms (SD) (years) | 4.9 (3.7) |
| Modified Hoehn and Yahr stage | |
| 1.0 | 3 (13.6) |
| 1.5 | 1 (4.5) |
| 2.0 | 15 (68.2) |
| 2.5 | 3 (13.6) |
| MDS-UPDRS II | 12.2 (7.9) |
| MDS-UPDRS III | 36.6 (17.1) |
| PDQ-8-SI | 27.4 (22.3) |
| NMSS | 37.8 (38.3) |
| LDED (mg) | 264.9 (220.7) |
| Comorbidities | |
| Hypertension | 7 (31.8) |
| Diabetes | 3 (13.6) |
| Hypothyroidism | 2 (9.1) |
Values expresses as frequency (%) or mean (standard deviation) or median (interquartile range). IQR=interquartile range; LDED=Levodopa equivalent dose; MDS-UPDRS=Movement Disorders Society-Unified Parkinson’s Disease Rating Scale; NMSS=Non-Motor Symptoms Scale; PDQ-8-SI=Parkinson’s Disease Questionnaire-8-Summary Index; SD=Standard deviation